Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Blood. 2009 Jan 29;113(5):1167-74. doi: 10.1182/blood-2008-06-161299. Epub 2008 Oct 27.

Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.

Author information

  • 1Blood and Marrow Transplantation Program, University of Minnesota, Minneapolis, MN 55455, USA. tolar003@umn.edu

Abstract

The recessive dystrophic form of epidermolysis bullosa (RDEB) is a disorder of incurable skin fragility and blistering caused by mutations in the type VII collagen gene (Col7a1). The absence of type VII collagen production leads to the loss of adhesion at the basement membrane zone due to the absence of anchoring fibrils, which are composed of type VII collagen. We report that wild-type, congenic bone marrow cells homed to damaged skin, produced type VII collagen protein and anchoring fibrils, ameliorated skin fragility, and reduced lethality in the murine model of RDEB generated by targeted Col7a1 disruption. These data provide the first evidence that a population of marrow cells can correct the basement membrane zone defect found in mice with RDEB and offer a potentially valuable approach for treatment of human RDEB and other extracellular matrix disorders.

Comment in

PMID:
18955559
[PubMed - indexed for MEDLINE]
PMCID:
PMC2635082
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk